News

Medyria AG, closed a CHF 1.5 million investment round, led by Lisbon-based venture capital fund Buenavista. This investment will propel Medyria’s innovative PyCath project forward. PyCath is a next ...
Auch der zuletzt schwache ICT- und Fintech-Sektor zeigte eine Erholung. Die investierte Summe nahm gegenüber dem ersten Halbjahr 2024 bei allgemeinen ICT-Startups um 86 Prozent auf 247 Millionen ...
By choosing b-rayZ as its AI partner, Affidea is taking a decisive step towards making precision medicine a reality. The b-rayZ solution is already in use in Affidea Switzerland, at Affidea’s Centre ...
H55, the Swiss electric aviation pioneer, reported that its Bristell B23 Energic completed more than 50 demonstration flights with potential buyers at Palo Alto Airport (KPAO) and turned multiple ...
ETH Zurich spin-off Invariant Labs has been bought by Snyk, the leader in secure AI software development. Invariant Labs is globally recognized as AI security research firm and early pioneer in ...
Planetary SA, a Swiss manufacturing platform specializing in biomass and precision fermentation at industrial scale, has acquired Libre Foods, a Barcelona-based pioneer in fungi-based food innovation.
The first Swiss Deep Tech Report demonstrates the strength of the Swiss ecosystem in comparison with other countries and provides a unique overview. A central theme is the use of AI.
103 early-stage startups have been selected to join MassChallenge Switzerland 2024 Accelerator Program, that’s 8% of applications received from around the world. Among the participants from 5 ...
The Lausanne-based startup Logmind has secured its seed financing round, led by Spicehaus Partners and backed by angel investors from four different countries. The funds will accelerate R&D efforts ...
Inspired by algorithmic trading techniques, Klepsydra develops high-performance software for edge data processing applications in real-time. Its unprecedented results can be applied to all kinds of ...
Monte Rosa Therapeutics, a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced a global license agreement with Novartis. Under the ...
NovaMea, a cleantech startup developing and commercializing electrochemical systems for energy storage and conversion, has raised $3.2 Million led by U.S. investor Lightspeed Venture Partners, one of ...